Skip to content

Study on the change of body fat distribution in obese patients and its correlation with myocardial tissue level characteristics

Study on the change of body fat distribution in obese patients and its correlation with myocardial tissue level characteristics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084974
Enrollment
Unknown
Registered
2024-05-29
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Case series:NA

Sponsors

Renji Hospital, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: i. Meet the diagnostic criteria for obesity (BMI=28kg/m2); Adult male waist =90cm, adult female waist =85cm, or waist-to-hip ratio > 1.0; ii. Ages 18-65; iii. Have not previously received any drug therapy or weight loss surgery affecting glucose and lipid metabolism; iv. Consent to venous blood collection and MRI examination without any contraindications related to examination;

Exclusion criteria

Exclusion criteria: i. have been diagnosed with secondary obesity, such as hypothyroidism, Cushing's syndrome, polycystic ovary syndrome, etc.; ii. Severe cardiovascular and cerebrovascular diseases, rheumatism and immunity diseases; iii. Severe metabolic diseases, such as diabetic ketoacidosis, hyperosmolar hyperglycemia, etc. iv. Advanced malignant tumors; v. Pregnancy and lactation; A known history of drug use that affects glycolipid metabolism, such as glucocorticoids, antibiotics, anti-anxiety or antidepressants; vii. Severe bleeding tendency and inability to complete venous blood collection; viii. There are MRI contraindications, such as patients with cardiac pacemakers, nerve stimulators, artificial metal heart valves, etc.; Pregnant patients; Claustrophobic; Epilepsy patients, etc. ix. Patients who refuse to undergo or are unable to cooperate with an MRI examination; x. Other conditions that the researcher deems inappropriate to study.

Design outcomes

Primary

MeasureTime frame
CMR;MRI of both lower limbs;Abdominal MRI;

Secondary

MeasureTime frame
Related indicators of glucose and lipid metabolism;

Countries

China

Contacts

Public ContactJing Ma

Renji Hospital, Shanghai Jiao Tong University

majing@renji.com+86 158 0098 3436

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026